SINFATIN 
SUSTAINABLE HEALTH

Sinfatin SL is a biotechnological company that was established in 2021 with a clear mission and vision. Our core mission is drug repositioning for neurological conditions, addressing unmet clinical needs and improving the quality of life for patients

 

Our vision is to become a global leader in innovative therapeutic solutions for central nervous system (CNS) diseases especially targeting fatigue (a common and disabling symptom with poor therapeutic solutions). To this end, we have developed novel advanced solutions and methodologies to drive innovation in this field. Our key assets lie in our expertise and intellectual property (IP)

 

The most advanced solution at this stage is repositioning of Rimonabant, a first-in-class treatment. Our IP covers different possible indications in which fatigue or other symptoms that we treat has no approved treatment, thus Rimonabant will be proposed as a first line treatment